Pembrolizumab and Disitamab Vedotin in HER2-expressing Metastatic Colorectal Cancer
收藏NIAID Data Ecosystem2026-03-13 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2719190
下载链接
链接失效反馈官方服务：
资源简介：
This is an open-label, multi-center, phase Ⅱ study. This study will evaluate the efficacy and safety of pembrolizumab in combination with disitamab vedotin in subject with HER2-expressing metastatic Colorectal Cancer (mCRC).
创建时间：
2022-07-15
